receivables 8. Others derivatives assets 9. Property, plant and equipment 10. Intangible assets 11. Other assets Total assets (Translation) -4- Liabilities and shareholders’ equity (Unit:Baht) Consolidated The
business receivables 8. Others derivatives assets 9. Property, plant and equipment 10. Intangible assets 11. Other assets Total assets (Translation) -4- Liabilities and shareholders’ equity (Unit:Baht
% Other components of equity 189 196 -3% Deduct: Treasury stock (114) 0 - Total equity of parent Company's shareholders 1,145 1,612 -29% Non-controlling interests 46 0 - Total Shareholders' Equity 1,191
- Share premium 6 6 - Retained earnings 1,270 1,229 +3% Other components of equity 196 199 -2% Total equity of parent Company's shareholders 1,612 1,575 +2% Non-controlling interests 0 5 - Total
a notice of the transaction to the shareholders within 21 days from the date of disclosure บริษัท ดีโอดี ไบโอเทค จ ำกัด (มหำชน) 111 หมู่ท่ี 2 ต ำบลท่ำจนี อ ำเภอเมืองสมุทรสำคร จังหวัดสมุทรสำคร 74000
สมุทรสำคร จังหวัดสมุทรสำคร 74000 111 Moo 2 Tambon Thachin,Amphur Muangsamutsakhon,Samutsakhon 74000,Thailand. including provide a notice of the transaction to the shareholders within 21 days from the date
the trust instrument. 8. REIT Manager Provide information on the REIT Manager containing at least the following particulars: (1) general information; (2) shareholders; specify the names of the following
attributed to the Company’s shareholders were THB 2,506 million, an increase of THB 1,348 million or 116.3%, representing a proportion to sales at 16.8%, an increase from the ratio of 8.0% in the corresponding
) 479,762 42.3 503,082 44.4 (23,320) (4.6) Shareholders’ equity 613,010 53.7 616,692 53.3 (3,682) (0.6) 653,202 57.7 630,128 55.6 23,074 3.7 Total liabilities and shareholders' equity 1,142,154 100.0
31, 2016, the financial position of the Company, which was analyzed by comparison and changes of assets, liabilities and shareholders’ equity, was as follows; Item For Year Ended December 31 (Unit